Login Preferences
About News Publications Statistics Downloads API Guide License How to use Preferences
bn:00378069n
Noun Concept
Categories: World Health Organization essential medicines, RTT, Specialty drugs, Monoclonal antibodies for tumors, All articles containing potentially dated statements
EN
rituximab  AntiCD20  ATC code L01XC02  ATCvet code QL01XC02  Blitzima
EN
Rituximab, sold under the brand name Rituxan among others, is a monoclonal antibody medication used to treat certain autoimmune diseases and types of cancer. Wikipedia
Definitions
Relations
Sources
EN
Rituximab, sold under the brand name Rituxan among others, is a monoclonal antibody medication used to treat certain autoimmune diseases and types of cancer. Wikipedia
A monoclonal antibody used in the treatment of leukemia, lymphomas, transplant rejection and autoimmune disorders Wikipedia Disambiguation
IS A
compound
medicine
monoclonal antibody
essential medicines
biopharmaceutical
HAS PART
carbon
MEDICAL CONDITION TREATED
arthritis
leukemia
chronic lymphocytic leukemia
multiple sclerosis
interstitial pneumonia
+25 relations
SUBJECT HAS ROLE
disease-modifying antirheumatic drug
Wikipedia
EN
rituximab
Wikidata
EN
rituximab
Wikipedia Redirections
EN
ATC code L01XC02, ATCvet code QL01XC02, Blitzima, MabThera, MabThera SC, Riabni, Ritemvia, Rituxan, Rituxan Hycela, rituximab-abbs, rituximab-arrx, rituximab-pvvr, rituximab/hyaluronidase, Rituximab and hyaluronidase human, Rituximab hyaluronidase, Rituxin, Rituzena, Rixathon, Riximyo, Ruxience, Truxima
Wikidata Alias
EN
AntiCD20, IDEC-102, IDEC-C2B8, Ig gamma-1 chain C region, Mabthera Rituxan, R-105 IDEC-102, RG-105, rituxan

Please note that, in order to improve your browsing experience on this website, BabelNet® uses various types of cookies, including: browsing functionality, performance and statistical cookies.

By continuing to browse the site you are agreeing to our use of cookies. OK

License